2026 COMPLIANCE: OUR PORTFOLIO IS FULLY OPTIMIZED FOR PRIVATE PRACTICE AND ASC SETTINGS UNDER THE 2026 FLAT-RATE UPDATES
Secure 2026 CMS Compliance and Protect Your Clinic Capital
RegenEdge pairs a curated, reimbursement‑readyclinical portfolio with custom practicefunding and working capital solutions.keeping you aligned with 2026 CMS flat‑rate rules
while eliminating upfront costs.
CORE DISTRIBUTION PORTFOLIO
01
AI IMAGING
Non-contact fluorescence to identify infection before a hospital readmission.
(CPT 0598T)
02
FISH COLLAGEN
Anhydrous Fish Collagen: High-performance, shelf-stable matrix.
(CPT A2014)
03
ACOUSTIC MIST
Portable, painless ultrasonic debridement mist.
(CPT 97610)
premium allografts
04
Premium, clinically proven allografts delivering enhanced margin optimization through exclusive RegenEdge provider pricing.
05
PRACTICE CAPITAL
Fast-closing replacement debt, commercial portfolio capital restructuring, and revenue-focused practice optimization for wound care growth.
06
WEBSITE
OPTIMIZATION
Capture high-intent wound care patients already searching online by improving your visibility and SiteScore trust.
NEW FOR 2026
PRACTICE INTEGRATION
We don’t just sell products. We deliver a comprehensive Practice Integration model. Our team supports seamless implementation and complex reimbursement navigation, keeping your clinical workflow efficient and compliant under the 2026 flat-rate updates. To remove adoption barriers, we now pair these compliant technologies with tailored working capital and practice funding solutions that eliminate upfront acquisition costs.
Practice Funding Steps
STEP 01
2026 Medicare Squeeze
The upcoming 2026 CMS flat-rate updates significantly tighten margins for private practices and ASCs, creating a critical need for reimbursement-ready clinical solutions.
STEP 02
Capital Accessibility Gap
Upfront capital requirements often prevent clinics from accessing advanced graft technology, stalling clinical outcomes and limitng patient care growth.
STEP 03
Customized Credit Solutions
RegenEdge bridges the cash-flow gap with customized lines of credit and equipment financing, ensuring you can deploy advanced technology today.
REIMBURSEMENT READY
FOR PRIVATE CLINICS & ASC
Dominate the 2026 CMS shift. Our clinical portfolio is built for flat-rate success, insulating your bottom line while ensuring total billing compliance. Don't leave your reimbursement to chance—partner with us for custom capital restructuring and secure your clinic’s financial future now.
READY TO OPTIMIZE YOUR REVENUE?
Request a Clinical Portfolio Review or Revenue Analysis to align your wound care strategy, reimbursement, and commercial portfolio capital restructuring for 2026 readiness.
"We believe that advanced regenerative technologies, when paired with clinical excellence and 2026-compliant billing, represent the pinnacle of patient healing and practice sustainability."